Cancer Types, Treatment and Research
Genetic Risk Factors in Breast Cancer
Breast cancer is the most common cancer and the second leading cause of cancer deaths in women in the United States. In 2008, approximately 184,450 patients were estimated to be diagnosed with invasive breast cancer, and an estimated 40,930 were estimated to die of this disease. Furthermore, over 50,000 female carcinoma in situ breast cases would have been diagnosed. The etiology of breast cancer is poorly understood with multiple genetic and environmental factors involved in the initiation and progression of cancer.
Scandinavian Twin Study: For years, there has been a hot debate as to whether the cause of breast cancer is genetic or environmental. Then in 2000, Lichtenstein and his colleagues at the Karolinska Institute in Sweden published their study of 44,788 pairs of twins from the Swedish, Danish, and Finnish twin registries. In this study, they looked at cancer risk with 28 different types of cancers and did statistical modeling of genetic and hereditary contributions in eleven different cancer types. For breast cancer, they clearly showed that only 27% of breast cancers were due to genetic factors. This was an even lower hereditary component than other common cancers such as prostate and colorectal. This study and others have confirmed the fact that over 70% of breast cancers are influenced by environmental factors.
BRCA genes: Although much attention has been made about hereditary breast cancer, only two genes are commonly tested for breast cancer risk assessment. These two genes are tumor suppressor genes named "BRCA1" and "BRCA2" that are involved with DNA repair. These two genes only account for about 5% of all breast cancers. Because of the Scandinavian twin study, most experts believed that there are other yet to be discovered genes involved with breast cancer. Because the chance of having a BRCA mutation in the general population is so low, genetic testing is not indicated in most patients. However, if a patient has a family history of breast cancer, then a mathematical model can be used to determine if BRCA testing is indicated. The likelihood of being a BRCA carrier increases with the number of relatives who had cancer and if the cancers occurred earlier in life. For example, in families with four or more cases of breast or ovarian cancer under the age of 60, over 80% are found to have a damaged version of BRCA1 or BRCA2. If a patient is a carrier of one or both of the BRCA1 and BRCA2 genes, her risk of breast cancer dramatically increases. According to estimates of lifetime risk, about 13.2% (132 out of 1,000 individuals) of women in the general population will develop breast cancer, compared with estimates of 36-85% (360–850 out of 1,000) of women with an altered BRCA1 or BRCA2 gene. In other words, women with an altered BRCA1 and/or BRCA2 gene are up to eight times more likely to develop breast cancer than women without alterations in those genes. The BRCA1 mutation confers a higher risk than a BRCA2 mutation. Women who inherit a damaged BRCA1 gene have a 60-85% chance of developing breast cancer at some stage in their lives and a 20-40% chance of developing ovarian cancer. For BRCA2, the risks are 40-60% and 10-20%, respectively.
Family History and Breast Cancer: Although the spotlight in hereditary breast cancer has been directed on the BRCA genes, the majority of patients with a family history of breast cancer are BRCA1 and BRCA2 negative. Even in these BRCA negative patients, however, there is an increased risk of developing cancer with a family history of breast cancer. Six factors (unrelated to BRCA genes) have been studied in patients with a family history of breast cancer. They are as follows:
1. Degree of relationship: If the family member with a history of cancer is a first degree relative, the increased risk is much greater than for second degree relatives. 2. Number of relatives who have had breast cancer: People with two or more family members who have had breast cancer are at higher risk than those with only one affected relative. 3. Age of onset of cancer: If the relative developed breast cancer at an early age (pre-menopausal), the risk is higher than if the relative developed post menopausal breast cancer. 4. Bilateral breast cancer: If the relative has a history of bilateral breast cancer, the risk is greater than having a relative with unilateral breast cancer. 5. Gender of the relative: If the family member with breast cancer is a man, the risk is higher. 6. Other related early onset tumors: If there is a family history of early onset ovarian cancer, this incurs an increased risk for a person.
How to decide whether you need the BRCA gene test
The following is an excerpt from the American Society of Breast Surgeons: 1. Early onset breast cancer (diagnosed before age 50) 2. Two primary breast cancers, either bilateral or ipsilateral 3. A family history of early onset breast cancer 4. Male breast cancer 5. A personal or family history of ovarian cancer 6. Ashkenazi (Eastern European) Jewish heritage 7. A previously identified BRCA1 or BRCA2 mutation in the family Any one of these features alone indicates a risk for harboring a BRCA1 or BRCA2 mutation. The presence of more than one of these features raises that risk to greater than 10%, the traditional cutoff for recommending a BRCA test. Such patients should have access to BRCA testing. A simple risk-calculation model based on the prevalence of mutations seen among women tested for BRCA mutations is available at http://www.brcacalculator.com.
Dr. Mai Brooks is a surgical oncologist/general surgeon, with expertise in early detection and prevention of cancer. More at www.drbrooksmd.com, thecancerexperience.wordpress.com and progressreportoncancer.wordpress.com.
Dr. Mai Brooks is a surgical oncologist/general surgeon, with expertise in early detection and prevention of cancer. More at www.drbrooksmd.com, thecancerexperience.wordpress.com and progressreportoncancer.wordpress.com
MORE ARTICLES:
Resource Website Directory
A helpful directory of websites and other online resources.
Bone Cancer - Types of Bone Cancer
Bone cancer types of cancer are a subcategory of cancers which afflict the bones There can be two ways in which cancerous cells may affect the bones
What Are The Risk Factors For Pancreatic Cancer?
Pancreatic cancer is currently the fifth most common form of cancer in the United States and is diagnosed in around 40,000 Americans each year In most cases pancreatic cancer has an extremely poor survival outcome
Sanford Cancer Center Expands
Sanford Hematology and Oncology Moves to New Location
Exposing the Double Standard of the Forgotten Cancer: Biggest Cancer Killer for Women and Men, Lung Cancer, Receives Least Research Funds
Lung Cancer Foundation of America (LCFA), , new organization trying to give the gift of life this holiday season by highlighting lack of research funding and providing critical support for lung cancer. Lung cancer remains biggest cancer killer for women and men yet receives least funds for research because lung cancer remains only cancer where victims are stigmatized and blamed for their disease.
Cholesterol and Cancer: Answers and Some New Questions
• Study shows low cholesterol as a symptom of cancer rather than a cause.
• Possible benefit of higher HDL and cancer risk.
• Lower cholesterol may lower risk of high-grade prostate cancer.
Lung Cancer: One of the Most Fatal Illnesses in the World
Lung cancer is one of the more prevalent kind of cancer Smoking is usually the culprit
St. Helena Hospital Cancer Center Affiliates with UCSF Medical Center to Enhance Local Cancer Treatment
The patient-centered, Martin-O'Neil Cancer Treatment Center at St. Helena Hospital offers world-class care, state-of-the-art technology and three types of oncology in one convenient location. The affiliation with the UCSF Helen Diller Family Comprehensive Cancer Center at UCSF Medical Center will provide North Bay patients with convenient access to cancer treatment specialists through a convenient Napa Valley location.
Men's Health Month: Recognize Your Individual Risk for Bladder Cancer
June is Men's Health Month. Bladder Cancer is more prevalent in men, especially military veterans, firefighters and cigarette smokers. The Men's Health Network offers information. Several physicians cite facts about the disease and insights on how to improve early detection.
Ovarian Cancer Vaccine Clinical Trial Begins At Cancer Treatment Centers of America
FDA-approved study aimed at harnessing immune system to fight tumors.
Senators Chuck Hagel and Dianne Feinstein Make Lung Cancer Matter
June 25, 2008 marks a revolutionary day in history for anybody who cares about Lung Cancer, the Number One Cancer Killer in this country. It's almost tantamount to July 4th, Independence Day, for Lung Cancer. For the first time, in the last four decades, Lung Cancer finally has a voice, thanks to Senators Chuck Hagel, Dianne Feinstein and the tireless work over the last five years of Laurie Fenton, Sheila Ross and the Lung Cancer Alliance.
Alternative Lung Cancer Treatment and You
Most of the people around the world die due to cancer, and one common cause that ties them together is lung cancer The standard age for the diagnosis of this disease is sixty
AACR CEO Margaret Foti Receives Honorary M.D. from The University of San Pablo CEU
Chief executive officer of the American Association for Cancer Research, Margaret Foti, Ph.D., M.D. (h.c.), honored for contributions to cancer research.
Cancer treatment - A non curable disease
The myth about cancer as a non curable disease is busted now. Though people scare for cancer disease since its recognition due to its deadly nature and non-availability of drugs, now cancer treatment is possible all over the world including India. Cancer treatments in India is modernized now with all modern infrastructures of instruments, facilities, availability of cancer specialists. Cancer is one of the most common reasons of deaths worldwide. India has both public and private sector institutes of cancer treatments and research. Therefore, medical tourists searching for cancer treatments can come to India to get rid off of this deadliest disease and rejuvenation of new life.
Skin Cancer Charts and Graphs
Cancer is a deadly disease especially when it is not detected early There is a lot of research going on currently in trying to find possible treatments for curing cancer
